[Federal Register Volume 80, Number 248 (Monday, December 28, 2015)]
[Proposed Rules]
[Pages 80718-80719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32471]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 101
[Docket No. FDA-2014-N-1207]
Use of the Term ``Natural'' in the Labeling of Human Food
Products; Request for Information and Comments; Extension of Comment
Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is extending the
comment period for a docket to receive information and comments on the
use of the term ``natural'' in the labeling of human food products,
including foods that are genetically engineered or contain ingredients
produced through the use of genetic engineering. A notice requesting
comments on this topic appeared in the Federal Register of November 12,
2015. We initially established February 10, 2016, as the deadline for
the submission of comments. We are taking this action
[[Page 80719]]
in response to requests for an extension to allow interested persons
additional time to submit comments.
DATES: FDA is extending the comment period for a docket to receive
information and comments on the use of the term ``natural'' in the
labeling of human food products. We established the docket in a notice
published on November 12, 2015 (80 FR 69905). Submit either electronic
or written comments to the docket by May 10, 2016.
ADDRESSES: You may submit comments by any of the following methods:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-N-1207 for ``Use of the Term `Natural' in the Labeling of
Human Food Products; Request for Information and Comments.'' Received
comments will be placed in the docket and, except for those submitted
as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Margaret-Hannah Emerick, Center for
Food Safety and Applied Nutrition (HFS-820), Food and Drug
Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 240-
402-2371.
SUPPLEMENTARY INFORMATION: In the Federal Register of November 12, 2015
(80 FR 69905), we published a notice announcing the establishment of a
docket to receive information and comments on the use of the term
``natural'' in the labeling of human food products, including foods
that are genetically engineered or contain ingredients produced through
the use of genetic engineering. The notice discussed FDA's position
regarding the use of the term ``natural'', the events that prompted us
to establish a docket to request comment on this issue, and specific
questions. We provided a 90-day comment period that was scheduled to
end on February 10, 2016.
We received requests for a 90-day extension of the comment period.
The requests conveyed concern that the current 90-day comment period
does not allow sufficient time to develop meaningful or thoughtful
comments to the questions and issues we presented in the notice.
FDA has considered the requests and is extending the comment period
for 90 days, until May 10, 2016. We believe that a 90-day extension
allows adequate time for interested persons to submit comments.
Dated: December 21, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-32471 Filed 12-24-15; 8:45 am]
BILLING CODE 4164-01-P